CME Group Inc.

🇺🇸NASDAQ Global Select
Back to all articles
CME Group Inc. stock analysis CME overview
Somewhat Bullish +45

CME Group Inc. (NASDAQ:CME) Receives Average Rating of "Moderate Buy ...

📊 CME Group holds a consensus 'Moderate Buy' rating with an average price target of $302.24 from eighteen analysts.

💰 The company beat Q1 earnings expectations, reporting $3.36 EPS and $1.88 billion in revenue.

📈 Revenue grew 14.5% year-over-year, driven by strong performance across derivatives exchanges.

💵 A quarterly dividend of $1.30 was declared with a 2.1% yield for shareholders of record June 9th.

📉 CEO Terrence Duffy sold 35,000 shares worth over $10 million, reducing his position by 38.62%.

🏦 Institutional ownership stands at 87.75%, with several funds increasing their stakes in Q3 and Q4.

📅 Analysts project full-year earnings per share of $12.28 for the current fiscal year.

🔄 Deutsche Bank lowered its price target to $322, while TD Cowen cut theirs to $273.

Bullish Signals
  • CME Group significantly beat quarterly earnings estimates with EPS of $3.36 versus a consensus of $3.11.
  • Revenue of $1.88 billion exceeded analyst expectations of $1.77 billion, showing robust demand.
  • The company achieved strong profitability metrics with a 63.19% net margin and 15.42% return on equity.
  • Year-over-year revenue growth of 14.5% indicates continued expansion in the derivatives market.
  • Analyst Rothschild & Co upgraded the stock to 'buy' and raised its price target to $323.
Risk Factors
  • Two analysts have assigned a 'sell' rating, indicating some bearish sentiment among the analyst community.
  • TD Cowen reduced its price target from $323.00 to $273.00, signaling potential downside concerns.
  • CEO Terrence Duffy sold 35,000 shares worth over $10 million, representing a 38.62% reduction in his stake.
Full Analysis
CME Group Inc. (NASDAQ:CME) has received a consensus analyst rating of 'Moderate Buy' based on reports from eighteen covering analysts, with twelve assigning a buy rating, four holding, and two selling. The average one-year price objective among brokers is $302.24. Recent analyst actions include Erste Group Bank lowering its rating to 'hold', Deutsche Bank reducing its price target to $322, Piper Sandler setting a $320 target, TD Cowen cutting its target to $273, and Rothschild & Co Redburn upgrading the stock to 'buy' with a $323 target. The company reported strong quarterly earnings on April 22nd, beating consensus estimates significantly. CME Group posted $3.36 in earnings per share compared to an expected $3.11, and revenue reached $1.88 billion against an estimate of $1.77 billion. Key financial metrics include a return on equity of 15.42%, a net margin of 63.19%, and year-over-year revenue growth of 14.5%. Analysts currently anticipate full-year earnings per share of $12.28. CME Group declared a quarterly dividend of $1.30 per share, payable on June 25th to shareholders of record as of June 9th, representing a 2.1% yield and a payout ratio of 44.37%. Insider trading activity saw CEO Terrence A. Duffy sell 35,000 shares for approximately $10.4 million, reducing his stake by 38.62%, while insider Hilda Harris Piell sold 5,753 shares for roughly $1.75 million. Institutional ownership remains high at 87.75%.